A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Stanford University
M.D. Anderson Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Emory University
PharmaMar
M.D. Anderson Cancer Center
Thomas Jefferson University
Cedars-Sinai Medical Center
Case Comprehensive Cancer Center
BeiGene
Blueprint Medicines Corporation
University Hospital, Antwerp
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Northwell Health
Prelude Therapeutics
Cedars-Sinai Medical Center
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
Lumos Pharma
National Cancer Institute (NCI)
University of Alabama at Birmingham
Mayo Clinic
Sumitomo Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SCRI Development Innovations, LLC
University of Nebraska
Canadian Cancer Trials Group
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Columbia University
AbbVie
Duke University
Case Comprehensive Cancer Center
Children's Oncology Group
Quadriga Biosciences, Inc.
CHA University
Radiation Therapy Oncology Group
Northwestern University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)